Furthermore, the tumor volume and weight were significantly reduced in the XCT-790 and sh-IGF2BP1 group compared with the XCT-790 or sh-IGF2BP1 groups alone (Fig. 7h and i). The gene discussed is IGF2BP1; the disease is neoplasm.